Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
Status:
Recruiting
Trial end date:
2022-12-20
Target enrollment:
Participant gender:
Summary
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits
the effectiveness of implant and increases the power consumption. Our aim in this study is to
benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the
fibrotic cascade.